Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus

Cytokine

Volumn 58, Issue 1, 2012, Pages 14-19

  Lopez Tinoco C ^a   Roca, M ^a   Fernandez Deudero A ^a   Garcia Valero A ^a   Bugatto, F ^a   Aguilar Diosdado, M ^a   Bartha, J L ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Cardiovascular disease risk; Cytokine; Gestational diabetes mellitus; Pregnancy

Indexed keywords

ADIPONECTIN; CELL ADHESION MOLECULE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE; INTERLEUKIN 6; LEPTIN; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; METABOLIC SYNDROME X; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; FEMALE; HUMANS; LEPTIN; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857455433     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.004     Document Type: Article

References (44)

1. Wolf M., Sauk J., Shah A., Vossen Smirnakis K., Jimenez-Kimble R., Ecker J.L., et al. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 2004, 27:21-27.
2. Richardson A.C., Carpenter M.W. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 2007, 34:213-244.
3. Albareda M., Caballero A., Badell G., Piquer S., Ortiz A., de Leiva A. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003, 26:1199-1205.
4. Lauenborg J., Mathiesen E., Hansen T., Glümer C., Jørgensen T., Borch-Johnsen J., et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005, 90:4004-4010.
5. Albareda M., Caballero A., Badell G., Rodríguez-Espinosa J., Ordóñez-Llanos J., et al. Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism 2005, 54:1115-1121.
6. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006, 67:879-891.
7. Pellme F., Smith U., Funahashi T., Matsuzawa Y., Brekke H., Wiklund O., et al. Circulating adiponectin level are reduced in nonobese but insulin-resistent first-degree relatives of type 2 diabetes patients. Diabetes 2003, 52:1182-1186.
8. Heitritter S., Solomon C., Mitchel G., Skali-ounis N., Seely E. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005, 90:3983-3988.
9. Metzger B.E. Summary and recommendations of the Third International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 1991, 40(Suppl. 2):197-201. The Organizing Committee.
10. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
11. Bo S., Menato G., Gallo M.L., Bardelli C., Lezo A., Signorile A., et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 2004, 83:335-340.
12. Bartha J.L., González-Bugatto F., Fernández-Macías R., González-González N.L., Comino-Delgado R., Hervías-Vivancos B. Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2008, 137:178-184.
13. Bays H., Mandarino L., DeFronzo R.A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004, 89:463-478.
14. Coughlan M.T., Oliva K., Georgiou H.M., Permezel H.M., Rice R.G. Glucose-induced release of TNF-α from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 2001, 18:921-927.
15. Chen J., Tan B., Karteris E., Zervou S., Digby J., Hillhouse E.W., et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokine. Diabetologia 2006, 49:1292-1302.
16. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., Challier J.C., Huston-Presley L., Friedman J.E., et al. TNF-î± is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
17. Winkler G., Cseh K., Baranyi E., Melczer Z., Speer G., Hajós P., et al. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 2002, 56:93-99.
18. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998, 83:2907-2910.
19. Verhaeghe M.D., Van Bree R., Lambin S., Caluwaerts S. Adipokine profile and C-reactive protein in pregnancy: effects of glucose challenge response versus body mass index. J Soc Gynecol Invest 2005, 12:330-334.
20. Kautzky-Willer A., Pacini G., Tura A., Bieglmayer C., Schneider B., Ludvik B., et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001, 44:164-172.
21. Simmons D., Breier B.H. Fetal overnutrition in polynesian pregnancies and in gestational diabetes may lead to dysregulation of the adipoinsular axis in offspring. Diabetes Care 2002, 25:1539-1544.
22. Retnakaran R., Hanley A.J.G., Raif N., Connelly P.W., Sermer M., Zinman B. Reduced adiponectin concentration in women with gestational diabetes. Diabetes Care 2004, 27:799-800.
23. Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001, 60:349-356.
24. National diabetes data group: classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28:1039-1057.
25. Carrascosa A., Ferrández A., Yeste D., García-Dihinx J., Romo A., Copil A., et al. Spanish cross-sectional growth study 2008. Part I: weight and height values in newborns of 26-42 weeks of gestational age. An Pediatr (Barc) 2008, 68:544-551.
26. Innes K.E., Wimsatt J.H. Pregnancy-induced hypertension and insulin resistance: evidence for a connection. Acta Obstet Gynecol Scand 1999, 78:263-284.
27. Solomon C.G., Willett W.C., Carey V.J., Rich-Edwards J., Hunter D.J., Colditz G.A., et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997, 278:1078-1083.
28. Knopp R.H., Chapman M., Bergelin R., Wahl P.W., Warth M.R., Irvine S. Relationships of lipoprotein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care 1980, 3:416-420.
29. Montelongo A., Lasuncion M.A., Pallardo L.F., Herrera E. Longitudinal study of plasma lipoprotein and hormones during pregnancy in normal and diabetic women. Diabetes 1992, 41:1651-1659.
30. Koukko E., Watts G.F., Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 1996, 49:634-637.
31. Gestational diabetes mellitus. Diabetes Care 1996, 27:88-90. America Diabetes Association.
32. Herranz L., Villaroel A., Riesco G., Martin-Vaquero P., Jañez M., González A. Elective delivery in women with gestational diabetes mellitus. Diabetología 2003, 46:A248-A249.
33. Chen C., Jin X., Meng X., Zheng C., Shen Y., Wang Y. Inhibition of TNFα-induced adhesion molecule expression by (Z)-(S)-9-octadecenamide, N-(2-hydroxyethyl,1-methyl). Eur J Pharmacol 2011, 660:305-309.
34. Zhang J., Alcaide P., Liu L., Sun J., He A., Luscinskas F.W., et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS ONE 2011, 6:452-455.
35. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-î±, in vivo. J Clin Endocrinol Metab 1997, 82:4196-4200.
36. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2000, 87:2084-2089.
37. Muller S., Martin S., Koenig W., Hanifi-Moghaddam P., Rathmann W., Haastert B., et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and coregulated acute-phase proteins but not TNF-α or its receptors. Diabetologia 2000, 45:805-812.
38. Atègbo J.M., Grissa O., Yessoufou A., Hichami A., Dramane K.L., Moutairou K., et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006, 91:4137-4143.
39. Bartha J.L., Martinez-del-Fresno P., Comino-Delgado R. Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy. Am J Obstet Gynecol 2001, 184:965-970.
40. Sivan E., Whittaker P.G., Sinha D., Homko C.J., Lin M., Reece E.A., et al. Leptin in human pregnancy: the relationship with gestational hormones. Am J Obstet Gynecol 1998, 179:1128-1132.
41. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human and possible biologicals roles. Eur J Endocrinol 2003, 148:293-300.
42. Retnakaran R., Hanley A.J., Raif N., Hirning C.R., Conelly P.W., Sermer M., et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetología 2005, 48:993-1001.
43. Ranheim T., Haugen F., Staff A.C., Braekke K., Harsem N.K., A Drevon C. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004, 83:341-347.
44. Georgiou H.M., Lappas M., Georgiou G.M., Marita A., Bryant V.J., Hiscock R., et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008, 45:157-165.